Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBF

Nuclear Medicine and Biology

Volumn 23, Issue 1, 1996, Pages 9-16

  Van Dyck, Christopher H ^a,c   Seibyl, John P ^a   Stubbs, James B ^b   Zoghbi, Sami ^a   Wisnieuiski, Gary ^a   Baldwin, Ronald M ^a   Zea Ponce, Yolanda ^a   Charney, Dennis S ^a   Hoffer, Paul B ^a   Innis, Robert B ^a  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

D2 dopamine receptor; Dosimetry; SPECT; 123I iodobenzofuran

Indexed keywords

DOPAMINE 2 RECEPTOR; IODINE 123; IODOBENZOFURAN I 123; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DOSIMETRY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; PHARMACOKINETICS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BENZOFURANS; FEMALE; HUMANS; IODINE RADIOISOTOPES; LIGANDS; MALE; PYRROLIDINES; RADIATION DOSAGE; RECEPTORS, DOPAMINE D2; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030019857     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02003-9     Document Type: Article

References (27)

1. 123I]2′-ISP in nonhuman primates. Nucl. Med. Biol 21, 969-976.
2. Brücke T., Podreka I., Angelberger P., Wenger S., Topitz A., Kufferle B., Muller C. and Deecke L. (1991) Dopamine D2 receptor imaging with SPECT: Studies in different neuropsychiatric disorders. J. Cereb. Blood Flow Metab. 11, 220-228.
3. Cloutier R., Watson E., Rohrer R. and Smith E. (1973a) Calculating the radiation dose to an organ. J. Nucl. Med. 14, 53-55.
4. Cloutier R. J., Smith S. A., Watson E. E., Snyder W. S. and Warner G. G. (1973b) Dose to the fetus from radionuclides in the bladder. Health Physics 25, 147-161.
5. Cristy M. and Eckerman K. (1987) Specific Absorbed Fractions of Energy at Various Ages from Internal Photon Sources. Oak Ridge National Laboratory, Oak Ridge, TN.
6. Dey H. M., Seibyl J. P., Stubbs J. B., Zoghbi S. S., Baldwin R. M., Smith E. O., Zubal I. G., Zea-Ponce Y., Olson C., Charney D. S., Hoffer P. B. and Innis R. B. (1994) Human biodistribution and dosimetry of the SPECT benzodiazepine receptor radioligand iodine-123-iomazenil. J. Nucl. Med. 35, 399-404.
7. Eckerman K. F., Cristy M. and Warner G. G. (1981) Dosimetric Evaluation of Brain Scanning Agents. In Proceedings of the Third International Radiopharmaceutical Dosimetry Symposium (Edited by Watson E. E. et al.), FDA 81-8166, pp 527-540, Oak Ridge, TN.
8. International Commission on Radiological Protection (1979) Limits for Intakes of Radionuclides by Workers. Pergamon Press, New York.
9. International Commission on Radiological Protection (1975) Task Group Report on Reference Man. Pergamon Press, Oxford, UK.
10. Kung H. F., Alavi A., Chang W., Kung M.-P., Keyes J. W. Jr., Velchik M. G., Billings J., Pan S., Noto R., Rausch A. and Reilley J. (1990a) In vivo SPECT imaging of CNS D-2 dopamine receptors: Initial studies with iodine-123 IBZM in humans. J. Nucl Med. 31, 573-579.
11. 123I]IBZM: A potential CNS D-2 dopamine receptor imaging agent. J. Nucl. Med. 30, 88-92.
12. Kung M.-P., Kung H. F., Billings J., Yang Y., Murphy R. A. and Alavi A. (1990b) Characterization of IBF as a new selective dopamine D-2 receptor imaging agent. J. Nucl. Med. 31, 648-654.
13. 2 receptors in healthy suhjects. J Nucl Med. 35, 743-754.
14. 2 dopamine receptor of patients with Parkinson's disease using single photon emission computed tomography and iodohenzamide I 123. Ann. Neurol. 50, 509-512.
15. Loevinger R. and Berman M. (1975) A Revised Schema for Calculating the Absorbed Dose from Biologically Distributed Radionuclides. Society of Nuclear Medicine, New York.
16. Mozley P. D., Stubbs J. B., Kung H. F., Selikson M. H., Stabin M. G. and Alavi A. (1993) Biodistribution and dosimetry of iodine-123-IBF: A potent radioligand for imaging the D2 dopamine receptor. J. Nucl. Med. 34, 1910-1917.
17. Murphy R. A., Kung H. F., Kung M.-P. and Billings J. (1990) Synthesis and characterization of iodobenzamide analogs: Potential D-2 dopamine receptor imaging agents. J. Med. Chem. 33, 171-178.
18. Pedro B. M., Gray N. S. and Pilowsky L. S. (1993) Dopamine D2 receptor binding in the basal ganglia in schizophrenia: Relationship to stereotypy. Schizophrenia Res. 9, 186.
19. Robertson J. (1983) Compartmental Distribution of Radiotracers. CRC Press, Boca Raton, FL, pp. 73-142.
20. Seibyl J. P., Wallace E., Smith E. O., Stabin M., Baldwin R. M., Zea-Ponce Y., Gao Y., Zhang Y. W., Neumeyer J. L., Zubal I. G., Charney D. S., Hoffer P. B. and Innis R. B. (1994) Whole-body biodistribution, radiation absorbed dose, and brain SPECT imaging with iodine-123-β-CIT in healthy human subjects. J. Nucl. Med. 35, 764-770.
21. Sorenson J. A. and Phelps M. E. (1987) Physics in Nuclear Medicine. W.B. Saunders, Philadelphia, PA.
22. Stabin M., Taylor A. Jr., Eshima D. and Wooter W. (1992) Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DPTA and iodine-131-OIH based on human biodistribution studies. J. Nucl. Med. 33, 33-40.
23. Stubbs J. B. and Marshall B. J. (1993) Radiation dose estimates for the carbon-14 labeled urea breath test. J. Nucl. Med. 34, 821-825.
24. Stubbs J. B., Vallabhajosula S., Lister-James J. and Smith T. D. (1993) Radiation dose estimates for Tc-99m P215: A peptide for imaging of atherosclerotic plaques. J. Nucl. Med. 34, 156P.
25. Tatsch K., Schwarz J., Oertel W. H. and Kirsh C. M. (1992) Dopamine D2 receptor imaging with I-123 IBZM SPECT to differentiate idiopathic from other Parkinson syndromes. J. Nucl. Med. 33, 917.
26. USP XXII (1990) Sterility tests 〈71〉. United States Pharmacopeial Convention, Inc., Rockville, MD. 22nd revision, pp. 1483-1486.
27. 123I-IBZM single photon emission computed tomography. Ann. Neurol. 50, 513-516.